Deep Polymers Ltd, Orissa Bengal Carrier Ltd, ANG Lifesciences India Ltd and Alps Industries Ltd are among the other losers in the BSE’s ‘B’ group today, 14 March 2023.

North Eastern Carrying Corporation Ltd leads losers in ‘B’ group

Nucleus Software Exports Ltd, Patel Engineering Ltd, ANG Lifesciences India Ltd and Creative Eye Ltd are among the other losers in the BSE’s ‘B’ group today, 10 March 2023.

Alps Industries Ltd leads losers in ‘B’ group

Ester Industries Ltd, Swelect Energy Systems Ltd, Zenith Steel Pipes & Industries Ltd and N K Industries Ltd are among the other losers in the BSE’s ‘B’ group today, 15 February 2023.

ANG Lifesciences India Ltd leads losers in ‘B’ group

ANG Lifesciences India Ltd. is a small-cap pharmaceutical company with a market worth of Rs. 184.99 crore.

Multibagger pharma stock announces record date for bonus issue

ANG Lifesciences India fixes record date for bonus issue of 1:4

Multibagger stock: ANG Lifesciences India Ltd has informed Indian bourses that its board of directors has recommended issuance of bonus shares in 1:4 ratio

Multibagger stock to consider 1:4 bonus share issue. Details here

Brightcom Group Ltd, Megastar Foods Ltd, ANG Lifesciences India Ltd and Jindal Poly Investment & Finance Company Ltd are among the other losers in the BSE’s ‘B’ group today, 09 March 2022.

Universus Photo Imagings Ltd leads losers in ‘B’ group

DCM Ltd, Brightcom Group Ltd, ANG Lifesciences India Ltd and Arihant Superstructures Ltd are among the other losers in the BSE’s ‘B’ group today, 08 March 2022.

Patel Integrated Logistics Ltd Partly Paidup leads losers in ‘B’ group

Coastal Corporation Ltd, Weizmann Ltd, Ashapuri Gold Ornament Ltd and ANG Lifesciences India Ltd are among the other losers in the BSE’s ‘B’ group today, 16 February 2022.

Arrow Greentech Ltd leads losers in ‘B’ group

GRP Ltd, Allied Digital Services Ltd, ANG Lifesciences India Ltd and Anand Rayons Ltd are among the other losers in the BSE’s ‘B’ group today, 02 February 2022.

Vishwaraj Sugar Industries Ltd leads losers in ‘B’ group

ANG Lifesciences India hit an upper circuit limit of 5% at Rs 521.65 after the company said it will invest in the equity shares of ANG Healthcare India.

ANG Lifesciences spurts after acquisition

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Strong financials and growth story over the years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

ANG Lifesciences India is a pharmaceutical company, engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials

ANG Lifesciences India Ltd